These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3012779)

  • 21. Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester.
    Truneh A; Albert F; Golstein P; Schmitt-Verhulst AM
    Nature; 1985 Jan 24-30; 313(6000):318-20. PubMed ID: 3918270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of phospholipase-D in Epstein Barr virus-transformed human B-cells.
    Foster KA; Gibb BA; Storch J
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):291S. PubMed ID: 8224439
    [No Abstract]   [Full Text] [Related]  

  • 23. Transcriptional activity across the Epstein-Barr virus genome in Raji cells during latency and after induction of an abortive lytic cycle.
    Kirchner EA; Bornkamm GW; Polack A
    J Gen Virol; 1991 Oct; 72 ( Pt 10)():2391-8. PubMed ID: 1655954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
    Ye J; Gradoville L; Daigle D; Miller G
    J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.
    Fahmi H; Cochet C; Hmama Z; Opolon P; Joab I
    J Virol; 2000 Jul; 74(13):5810-8. PubMed ID: 10846060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.
    Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of replication of Epstein-Barr virus DNA in human lymphoblastoid cell lines by N-methyl-N'-nitro-N-nitrosoguanidine.
    Lin JC; Smith MC; Pagano JS
    Carcinogenesis; 1983; 4(2):185-8. PubMed ID: 6297823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of 12-O-tetradecanoyl-phorbol-13-acetate on the replication of Epstein-Barr virus. I. Characterization of viral DNA.
    Lin JC; Shaw JE; Smith MC; Pagano JS
    Virology; 1979 Nov; 99(1):183-7. PubMed ID: 227161
    [No Abstract]   [Full Text] [Related]  

  • 29. Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes.
    Woisetschlaeger M; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6498-502. PubMed ID: 2549539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cocaine potentiates the switch between latency and replication of Epstein-Barr virus in Raji cells.
    Di Francesco P; Lisi A; Rieti S; Manni V; Grimaldi S; Garaci E
    Biochem Biophys Res Commun; 1999 Oct; 264(1):33-6. PubMed ID: 10527836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.
    Sample J; Brooks L; Sample C; Young L; Rowe M; Gregory C; Rickinson A; Kieff E
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6343-7. PubMed ID: 1648738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
    Doyle MG; Crawford DH
    Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus induction by a serum factor. Characterization of the purified factor and the mechanism of its activation.
    Bauer G; Höfler P; Simon M
    J Biol Chem; 1982 Oct; 257(19):11411-5. PubMed ID: 6288683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunocytochemical evidence for translocation of protein kinase C in human megakaryoblastic leukemic cells: synergistic effects of Ca2+ and activators of protein kinase C on the plasma membrane association.
    Ito T; Tanaka T; Yoshida T; Onoda K; Ohta H; Hagiwara M; Itoh Y; Ogura M; Saito H; Hidaka H
    J Cell Biol; 1988 Sep; 107(3):929-37. PubMed ID: 3047154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of secretagogues on cytoplasmic free calcium in alveolar type II epithelial cells.
    Sano K; Voelker DR; Mason RJ
    Am J Physiol; 1987 Nov; 253(5 Pt 1):C679-86. PubMed ID: 2825530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of arabinofuranosylthymine on Epstein-Barr virus replication.
    Ooka T; Calender A
    Virology; 1980 Jul; 104(1):219-23. PubMed ID: 6249024
    [No Abstract]   [Full Text] [Related]  

  • 37. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.
    Hochberg D; Middeldorp JM; Catalina M; Sullivan JL; Luzuriaga K; Thorley-Lawson DA
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):239-44. PubMed ID: 14688409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
    De Leo A; Arena G; Stecca C; Raciti M; Mattia E
    Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus replication in interferon-treated cells.
    Sharp NA; Arrand JR; Clemens MJ
    J Gen Virol; 1989 Sep; 70 ( Pt 9)():2521-6. PubMed ID: 2550580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence of a repressed Epstein-Barr virus genome in Burkitt lymphoma cells made resistant to 5-bromodeoxyuridine.
    Hampar B; Derge JG; Martos LM; Walker JL
    Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3185-9. PubMed ID: 4332012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.